DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Critical Care Therapeutics Market 2017-2021" report to their offering.
The global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.
The report, Global Critical Care Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, one driver in market is increasing surgical procedures. The increasing surgical procedures such as hip and knee replacements will increase the risk of DVT, thereby driving the market growth. Surgeries often result in long periods of immobility, thus increasing the chances of developing DVT due to reduced blood flow. It is reported that over a million Americans undergo joint replacement surgeries every year. Individuals undergoing knee replacement and hip replacement surgeries have an increased likelihood of developing DVT. For instance, according to the CDC 2015 report, around 719,000 knee replacement surgeries and 332,000 hip replacement surgeries are performed in the US every year.
Key vendors:
- CSL Behring
- Grifols
- Kedrion Biopharma
- Octapharma
-
Shire
Other prominent vendors:
- Abeona Therapeutics
- ADMA Biologics
- Albumedix
- Armetheon
- Asklepios BioPharmaceutical
- Aspen Pharma
- Baxter
- Bayer HealthCare
- Bio Products Laboratory
- BioDelivery Sciences
- Biogen Idec
-
Others
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Global critical care therapeutics: Market landscape
Part 06: Market segmentation by drug class
Part 07: Market segmentation by application
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Market challenges
Part 11: Impact of drivers and challenges
Part 12: Market trends
Part 13: Vendor landscape
Part 14: Key vendor analysis
Part 15: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/7k7m4d/global_critical